RESUMO
Cannabidiol (CBD) has significant therapeutic potential; nevertheless, its advance as an effective drug by the pharmaceutical business is hindered by its inherent characteristics, such as low bioavailability, low water solubility, and variable pharmacokinetic profiles. This research aimed to develop nanoliposomes using an easy and low-cost method to improve the hydrosolubility of CBD and achieve a controlled delivery of the active principle under relevant physiological conditions from the mouth to the intestine; the cytotoxic and antitumor activities were also evaluated. To achieve the objective, core-shell nanoliposomes based on CBD were synthesized in three easy steps and characterized in terms of shape, size, surface chemistry, thermal capacity, and surface charge density through transmission electron microscopy (TEM), dynamic light scattering (DLS), Fourier transform infrared (FTIR), thermogravimetric analysis (TGA), and potential charge (PZ), respectively. CBD-controlled delivery trials were carried out under simulated mouth-duodenal conditions and fitted to Korsmeyer-Peppas and Noyes-Whitney models to conclude about the pharmacokinetics of CBD from nano-CBD. Cytotoxicity studies on nonmalignant human keratinocytes (HaCaT) were carried out to evaluate its safety and the recommended consumption dose, and finally, the antiproliferative capacity of nano-CBD on human colon carcinoma cells (SW480) was determined as beginning proposal for cancer treatment. The characterization results verified the water solubility for the CBD nanoencapsulated, the core-shell structure, the size in the nanometric regime, and the presence of the synthesis components. The dissolution rate at duodenal conditions was higher than that in buccal and stomach environments, respectively, and this behavior was associated with the shell (lecithin) chemical structure, which destabilizes at pH above 7.2, allowing the release by non-Fickian diffusion of CBD as corroborated by the Korsmeyer-Peppas model. In vitro biological tests revealed the innocuousness and cyto-security of nano-CBD up to 1000 mg·L-1 when evaluated on HaCaT cells and concentrations higher than 1000 mg·L-1 showed antitumor activity against human colon carcinoma cells (SW480) taking the first step as a chemotherapeutic proposal. These results are unprecedented and propose a selective delivery system based on nano-CBD at low cost and that provides a new form of administration and chemo treatment.
RESUMO
Wax deposition in high-wax (waxy) crude oil has been an important challenge in the oil and gas industry due to the repercussions in flow assurance during oil extraction and transportation. However, the nanotechnology has emerged as a potential solution for the optimization of conventional wax removal and/or inhibition processes due to its exceptional performance in the alteration of wax morphology and co-crystallization behavior. In this sense, this study aims to study the performance of two commercial wax inhibitor treatments (WT1 and WT2) on the wax formation and crystallization due to the addition of SiO2 nanoparticles. Differential scanning calorimetry experiments and cold finger tests were carried out to study the effect of the WT on wax appearance temperature (WAT) and the wax inhibition efficiency (WIE) in a scenario with an initial temperature difference. In the first stage, the behavior of both WT in the inhibition of wax deposition was achieved, ranging in the concentration of the WT in the waxy crude (WC) oil from 5000 to 50,000 mg·L-1. Then, NanoWT was prepared by the addition of SiO2 nanoparticles on WT1 and WT2 for concentrations between 1000 and 500 mg·L-1, and the performance of the prepared NanoWT was studied at the best concentration of WIT in the absence of nanoparticles. Finally, the role of the nanofluid concentration in wax inhibition was accomplished for the best NanoWT. Selected NanoWT with nanoparticle dosage of 100 mg·L-1 added to WC oil at 5000 mg·L-1 displays reductions in WAT and WIE of 15.3 and 71.6 for NanoWT1 and -2.2 and 42.5% for NanoWT2. In flow loop experiments for the crude oil at temperatures above (30 °C) and below (16 °C), the WAT value indicates an increase of 8.3 times the pressure drops when the crude oil is flowing at a temperature below the WAT value. Therefore, when NanoWT1 is added to the crude oil, a reduction of 31.8% was found in the pressure drop in comparison with the scenario below the WAT value, ensuring the flow assurance in the pipeline in an unfavorable environment. Based on the pressure-drop method, a reduction greater than 5% in the wax deposit thickness confirms the wax deposition inhibitory character of the designed NanoWT.